中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性硬化性胆管炎的治疗进展

鲍正华 韩真

引用本文:
Citation:

原发性硬化性胆管炎的治疗进展

详细信息
  • 中图分类号: R575.7

Progress in the treatment of primary sclerosing cholangitis

  • 摘要: 原发性硬化性胆管炎(PSC)是一种原因不明的慢性胆汁淤积性自身免疫性肝病,其确切的发病机制尚未明确,可能与遗传、免疫、损伤等多种因素有关,诊断及治疗均较为困难。本文就原发性硬化性胆管炎的治疗作一综述,以期加深对该病的了解,为进一步的临床治疗提供依据。

     

  • [1]胆汁淤积性肝病诊断治疗专家委员会.胆汁淤积性肝病诊断治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2009, 3 (4) :60-61.
    [2]Maggs JR, Chapman RW.An update on primary sclerosingcholangitis[J].Curr Opin Gastroenterol, 2008, 24 (3) :377-383.
    [3]Beuers U.Drug insight:Mechanisms and sites of actionof ursodeoxycholic acid in cholestasis[J].Nat Clin PractGastroenterol Hepatol, 2006, 3 (6) :318-328.
    [4]European Association for the Study of the Liver.ESAL ClinicalPractice Guidelines:management of cholestatic liver disease[J].J Hepatol, 2009, 51 (2) :237-267.
    [5]Olsson R, Boberg KM, de Muckadell OS, et al.High-doseursodeoxycholic acid in primary sclerosing cholangitis:a 5-yearmulticenter, randomized, controlled study[J].Gastroenterology, 2005, 129 (5) :1464-1472.
    [6]Rost D, Rudolph G, Kloeters-plachky P, et al.Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primarysclerosing cholangitis[J].Hepatology, 2004, 40 (3) :693-698.
    [7]陆伦根, 田丽艳, 徐铭益, 等.欧洲肝病学会临床实践指南:胆汁淤积性肝病的治疗 (3) [J].肝脏, 2010, 15 (1) :44-48.
    [8]Herszényi L, Farinati F, Miheller P, et al.Chemoprevention ofcolorectal cancer:feasibility in everyday practice[J].Eur JCancer Prev, 2008, 17 (6) :502-514.
    [9]Rudolph G, Kloeters-Plachky P, Rost D, et al.The incidenceof cholangiocarcinoma in primary sclerosing cholangitisafter long-time treatment with ursodeoxycholic acid[J].Eur JGastroenterol Hepatol, 2007, 19 (6) :487-491.
    [10]Chapman R, Fevery J, Kalloo A, et al.Diagnosis and management of primary sclerosing cholangitis[J].Hepatology, 2010, 51 (2) :660-678.
    [11]Mato JM, Lu SC.Role of S-adenosyl-L-methionine in liverhealth and injury[J].Hepatology, 2007, 45 (5) :1306-1312.
    [12]Lu SC, Mato JM.S-Adenosylmethionine in cell growth, apoptosis and liver cancer[J].J Gastroenterol Hepatol, 2008, 23 (Suppl 1) :S73-77.
    [13]Chen W, Gluud C.Glucocorticosteroids for primary sclerosingcholangitis[J].Cochrane Patabase Syst Rev, 2010, 20 (1) :CD004036.
    [14]Arulprakash S, Sasi AD, Bala MR, et al.Overlap syndrome:autoimmune hepatitis with primary biliary cirrhosis[J].J AssocPhysicians India, 2010, 58:455-456.
    [15]Sandborn WJ, Wiesner RH, Tremaine WJ, et al.Ulcerative colitisdisease activity following treatment of associated primarysclerosing cholangitis with cyclosporin[J].Gut, 1993, 34 (2) :242-246.
    [16]邱德凯, 马雄.自身免疫性肝病基础与临床[M].上海:上海科学技术出版社, 2006:281-287.
    [17]Van Thiel DH, Carroll P, Abu-Elmagd K, et al.Tacrolimus (FK506) , a treatment for prima-ry sclerosing cholangitis:results ofan open-label preliminary trial[J].Am J Gastroenterol, 1995, 90 (3) :455-459.
    [18]Talwalkar JA, Gossard AA, Keach JC, et al.Tacrolimus for thetreatment of primary sclerosing cholangitis[J].Liver Int, 2007, 27 (4) :451-453.
    [19]Olsson R, Bmome U, Danielsson A, et al.Colchicine treatmentof primary sclemsing eholang-itis[J].Gastroenterology, 1995, 108 (4) :1199-1203.
    [20]Farkkila M, Karvonen AL, Nurmi H, et al.Metronidazole andursodeoxycholic acid for prim-ary sclerosing cholangitis:arandomized placebo-controlled trial[J].Hepatology, 2004, 40 (6) :1379-1386.
    [21]Gluck M, Cantone NR.Brandabur JJ, et al.A twenty-yearexperience with endoscopic therapy for symptomatic primarysclerosing cholangitis[J].J Clin Gastroenterol, 2008, 42 (9) :1032-1039.
    [22]Aljiffry M, Renfrew PD, Walsh MJ, et al.Analytical review ofdiagnosis and treatment strategies for dominant bile ductstrictures in patients with primary sclerosing.cholangitis[J].HPB (Oxford) , 2011, 13 (2) :79-90.
    [23]Wagner S, Gebel M, Meier P, et al.Endoscopic managementof biliary tract strictures in primary sclerosing cholangitis[J].Endoscopy, 1996, 28 (7) :546-551.
    [24]Pawlik TM, Olbrecht VA, Pitt HA, et al.Primary sclerosingcholangitis:role of extrahepatic biliary resection[J].J Am CollSurg, 2008, 206 (5) :822-830.
    [25]Alabraba E, Nightingale P, Gunson B, et al.A re-evaluation of therisk factors for the recurrence of primary sclerosing cholangitis inliver allografts[J].Liver Transpl, 2009, 15 (3) :330-340.
    [26]Kingham JG, Kochar N, Gravenor MB.Incidence, clinicalpatterns, and outcomes of primary sclerosing cholangitis inSouth Wales, United Kingdom[J].Gastroenterology, 2004, 126 (7) :1929-1930.
  • 加载中
计量
  • 文章访问数:  3255
  • HTML全文浏览量:  9
  • PDF下载量:  980
  • 被引次数: 0
出版历程
  • 出版日期:  2011-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回